Elenco degli articoli con argomento «psoriasi»
Dermatologia04 dic 2024
A prospective Real-Life Multicenter Study of Tildrakizumab
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis
23 lug 2024
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patient
Night shift work disrupts circadian rhythms and has been associated with immune system alterations and various health conditions
09 lug 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis
Guselkumab is the first approved human IgG1λ monoclonal antibody selectively targeting the p19 subunit of IL23
06 giu 2024
Metti la Psoriasi Fuorigioco
Campagna patrocinata SIDeMaST “Metti la Psoriasi Fuorigioco” è una campagna multicanale di sensibilizzazione sulla psoriasi.
03 giu 2024
Gestire la psoriasi in gravidanza
La psoriasi è una malattia infiammatoria cronica caratterizzata da un aumentato turnover cellulare dell’epidermide
05 apr 2024
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia
Genital involvement is observed in approximately 60% of patients with psoriasis
19 dic 2023
Sex differences in adverse events from systemic treatments for psoriasis
Psoriasis is a disease that often requires prolonged systemic treatment
19 dic 2023
Spesolimab in patients with flare of generalized pustular psoriasis
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series
06 dic 2023
Nail Psoriasis & Nail Lichen Planus
Inflammatory diseases of the nail, including nail psoriasis and nail lichen planus
06 dic 2023
Iatrogenic switch from psoriasis to eczema
Iatrogenic switch from psoriasis to eczema: What does it mean and is it predictable?
25 ott 2023
Exposure to biologic therapy
Biologicals have transformed the management of severe disease phenotypes in psoriasi
05 giu 2023
Oral orismilast
Orismilast is a high-potency phosphodiesterase 4 (PDE4) inhibitor with enhanced selectivity for the PDE4B and PDE4D subtypes
15 mag 2023
Quattro eventi SIDeMaST questo mese - maggio 2023
Tre webinar e una FAD con accreditamento ECM
04 mag 2023
Criteria used to define tumor
Determining tumor necrosis factor-alpha inhibitors (anti-TNF-α) failure is still a challenge in the management of moderate-to-severe
17 apr 2023
Bimekizumab maintenance of response through three years
Given the chronic nature of psoriasis and the loss of response that can be observed with therapies over time
20 feb 2023
Psoriatic Arthritis in Males and Females
To assess any differences and similarities in psoriatic arthritis (PsA) between sexes.
20 feb 2023
A Review on the Safety of Using JAK Inhibitors in Dermatology
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions
19 dic 2022
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis
Effective, well-tolerated oral psoriasis treatments are needed.
13 dic 2022
Comparative effectiveness of biologics in clinical practice
Clinical trials study treatment outcomes under stringent conditions.
08 nov 2022
The risk of COVID-19 in patients with psoriasis
The risk of COVID-19 in patients with psoriasis: A retrospective cohort study